Spiro Medical is revolutionizing the treatment paradigm for patients with severe, chronic airway diseases.
Investors 2
Mentions in press and media 4
| Date | Title | Description |
| 13.01.2026 | Spiro Medical Secures $67M to Revolutionize Asthma Treatment with PNM System | Spiro Medical secured $67 million in Series A funding. This capital fuels development of its innovative Pulmonary Neuromodulation System (PNM). PNM offers a novel, drug-free approach for severe asthma. It uses mild electrical impulses to co... |
| 08.01.2026 | Startup Spiro Medical snares $67M in series A funding for asthma treatment | Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel treatment for asthma.
Dubbed the Pulmonary Neuromodulation System, the platform is touted by the company as a first of it... |
| 07.01.2026 | Spiro Medical Raises $67M in Series A Funding | Spiro Medical, an Irvine, CA-based medtech company developing a pulmonary neuromodulation system (PNM) for the treatment of asthma, raised $67M in Series A funding.
The round included a syndicate of venture investors led by Andera Partners ... |
| - | Spiro Medical | “Spiro Medical is revolutionizing the treatment paradigm for patients with severe, chronic airway diseases.” |
Reviews 0
